Thyroid MALT lymphoma: self-harm to gain potential T-cell help.

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) arises from chronic inflammation and genetic mutations.
• Thyroid MALT lymphoma, a specific subtype, requires investigation into its underlying genetic drivers.

Purpose of the Study:

• To identify the genetic alterations driving thyroid MALT lymphoma development.
• To explore the relationship between genetic mutations and the tumor microenvironment, including T-cell activation.
• To investigate associations between genetic changes and clinical features like Hashimoto's thyroiditis.

Main Methods:

• Targeted sequencing of 93 genes was performed on 131 MALT lymphoma samples, with a focus on 76 thyroid MALT lymphomas.
• Analysis included mutation detection and copy number variation assessment (e.g., CD274 deletion).
• Statistical analyses were used to assess associations between genetic alterations, T-cell populations, and clinical parameters.

Main Results:

• Frequent deleterious mutations were observed in TET2 (86%), CD274 (53%), TNFRSF14 (53%), and TNFAIP3 (30%) in thyroid MALT lymphoma.
• CD274 mutations and deletions occurred in 68% of cases, often co-occurring with TNFRSF14 mutations (p=0.001).
• CD274/TNFRSF14 genetic abnormalities correlated with increased activated T-cells near malignant B-cells and were associated with Hashimoto's thyroiditis.

Conclusions:

• Inactivation of CD274 (PD-L1) and TNFRSF14 in thyroid MALT lymphoma B-cells disrupts T-cell interactions, potentially promoting co-stimulation.
• These genetic changes may impair peripheral tolerance, contributing to lymphoma development.
• The findings highlight the role of immune dysregulation in thyroid MALT lymphoma pathogenesis.